Pharmaceutical products containing denosumab

Summary

The procurement concerns the supply of pharmaceutical products containing denosumab in three lots: 60 mg/ml pre-filled syringes and 120 mg pre-filled syringes or injection vials. Tenderers must meet the lot-specific turnover thresholds, prove registration with the medicines authority or an equivalent European body, and submit an electronic tender with a 5% tender guarantee. Price is the only award criterion, and the submission deadline is 19 October 2026 at 11:00.